Практические Рекомендации По Нутритивной Поддержке Онкологических Больных

Сытов, А. В.; Зузов, С. А.; Кукош, М. Ю.; Leiderman, I. N.; Потапов, А. Л.; Хотеев, А. Ж.

doi:10.18027/2224-5057-2021-11-3s2-43

Cited by 8 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В исследование были включены 40 пациентов с ге мобластозами, у которых был выявлен риск развития нутритивной недостаточности или уже имело место нарушение нутритивного статуса согласно оценке по шкале NRS 2002 [23]. Также принимали во внима ние клиниколабораторные критерии недостаточности питания (табл.…”

Section: материалы и методыunclassified

Influence of nutritional support on tolerability and results of treatment in patients with newly diagnosed hemoblastoses received program chemotherapy

Shen

Minin

Gaydym³

et al. 2022

Onkogematologiâ

View full text Add to dashboard Cite

Background. Nutritional deficiency in malignant hematological diseases is a common condition that contributes to a decrease in functionality, tolerability of anticancer treatment and patient quality of life, and an increase in mortality rates. Often, malnutrition develops even before the start of anticancer treatment or during therapy and often remains unrecognized up to pronounced stages. despite the obvious importance of assessing and correcting the nutritional status in patients with hematological malignancies, this problem remains poorly understood.Aim. To evaluate the effect of nutritional support on the tolerability and results of treatment in patients with hemoblastoses.Materials and methods. The study included 40 patients with newly diagnosed hemoblastoses with nutritional deficiency or at risk of its development, who received program chemotherapy. patients were randomized into 2 comparable groups: in the main group (n = 20) patients received 2–3 bottles of Nutridrink compact protein mixture per day for 30 days, in the control group (n = 20) they ate at their own discretion without the use of additional enteral nutrition.Results. Comparative results of laboratory monitoring showed a significant increase in albumin levels in the main group compared with the control group (p <0.01). In the main group, less severe gastrointestinal toxicity of systemic anticancer therapy was observed: a tendency to a lower incidence of diarrhea and mucositis, a statistically significant reduction in the frequency of constipation, and a significant 2.8-fold decrease in the frequency of taste changes (25 % versus 70 %). Assessment of hematological toxicity showed that pancytopenia persisted in the control group (decrease in leukocytes, erythrocytes, hemoglobin, hematocrit and platelets levels), which was absent in the main group; leukocytes, hemoglobin, hematocrit, platelets and eosinophils were statistically significantly lower compared to the main group.Conclusion. The use of the Nutridrink compact protein mixture within 30 days from the start of treatment in patients with newly diagnosed hemablastoses contributed to an increase in albumin level, and reduced the incidence of gastrointestinal and hematological toxicity during systemic antitumor therapy.

show abstract

Section: материалы и методыunclassified

Influence of nutritional support on tolerability and results of treatment in patients with newly diagnosed hemoblastoses received program chemotherapy

Shen

Minin

Gaydym³

et al. 2022

Onkogematologiâ

View full text Add to dashboard Cite

show abstract

“…При этом в большинстве международных рекомендаций, в том числе рекомендаций Российского общества клинической онкологии (RUSSCO) от 2021 г., отмечено, что к нутритивной поддержке на фоне лечения ЗНО следует относиться не как к опции, а как к обязательному компоненту лечения, ее следует начинать как можно раньше (при наличии показаний), поскольку при легкой степени питательной недостаточности гораздо проще стабилизировать нутритивный статус и предотвратить тяжелое истощение вследствие прогрессирования катаболизма. При этом скрининг нутритивного статуса должен применяться также у амбулаторных пациентов, так как у каждого третьего из них развивается тяжелое истощение [15].…”

Section: диетотерапия и нутритивная поддержкаunclassified

Comprehensive rehabilitation of cancer patients: A review

et al. 2022

View full text Add to dashboard Cite

Due to the improvement of the results of combined treatment of malignant tumors the survival rate of cancer patients is increasing. The issue of improving the quality of life, both during treatment and after its completion, is becoming more and more urgent. Conducting an individually selected comprehensive rehabilitation treatment conducted by a multidisciplinary team aimed at correcting not only medical problems but also the social capabilities of the patient taking into account the personal experience of the patient, his psychological traits, habits, etc., helps reduce the number of complications significantly, improve the quality of life of patients. The article discusses the stages, methods of rehabilitation, nutritional support for cancer patients.

show abstract